1 |
Gerlach, M., Riederer, P. and Youdim, M. B. H. : The molecular pharmacology of l-deprenyl. European Jounal of Pharmacology-Molecular Pharmacology Section 226, 97 (1992)
DOI
ScienceOn
|
2 |
Carrillo, M. C., Kanai, S., Nokubo, M. and Kitani, K. : Deprenyl induced activities of both superoxide dismutase & catalase but not of glutathione peroxidase in the striatum of young male rat. Life Sci. 48, 517 (1991)
DOI
ScienceOn
|
3 |
Walkinshaw, G. and Waters, C. M. : Neurotoxin induced cell death in neuronal PC12 cells is mediated by induction of apoptosis. Neuroscience 63, 975 (1994)
DOI
ScienceOn
|
4 |
Ochu, E. E., Rothwell, N. J. and Waters, C. M. : Caspases mediate 6-hydroxydopamine-induced apoptosis but not necrosis in PC12 cells. J. Neurochem. 70, 2637 (1998)
DOI
ScienceOn
|
5 |
Knoll, J. : The striatal dopamine dependency of life span in male rats, longevity study with (-) deprenyl. Mech. Aging Dev. 46, 237 (1988)
DOI
ScienceOn
|
6 |
Cohen, G. and Spina, M. B. : Deprenyl supresses the oxidant stress associated with increased dopamine turnover. Ann. Neurol. 26, 689 (1989)
DOI
ScienceOn
|
7 |
Scarr, E., Wingerchuck, D. M., Juorio, A. V. and Paterson, I. A. : The effects of monoamine oxidase B inhibition on dopamine metabolism in rats with nigro-striatal lesions. Neurochem. Res. 19, 153 (1994)
DOI
ScienceOn
|
8 |
Leist, M. and Nicotera, P. : Apoptosis, excitotoxicity and neuropathology. Experimental Cell Reasearch 239, 183 (1998)
DOI
ScienceOn
|
9 |
Mosmann, T. : Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55 (1983)
DOI
PUBMED
ScienceOn
|
10 |
Tatton, W. G. and Chalmers-Redman, R. M. E. : Modulation of gene expression rather than monoamine oxidase inhibition : (-)-Deprenyl-related compounds in controlling neurodegeneration. Neurology 47(Supple 3), S171 (1996)
DOI
|
11 |
Kragten, E., Lalande, I., Zimmermann, K., Roggo, S., Schindler, P., Muller, D., Oostrum, J. V., Waldmeier, P. and Furst, P. : Glyceraldehyde-3-phosphate dehydrogenase, the putative target of the antiapoptotic compounds CGP 3466 and R-(-)-deprenyl. J. Biol. Chem. 273, 5821 (1998)
DOI
ScienceOn
|
12 |
Mochizuki, H., Goto, K., Mori, H. and Mizuno, Y. : Histochemical detection of apoptosis in Parkinson's disease. J. Neural. Sci. 137, 120 (1996)
DOI
ScienceOn
|
13 |
Marti, M. J., James, C. J., Oo, T. F., Kelly, W. J. and Burke, R. E. : Early developmental destruction of terminals in the striatal target induce apoptosis in dopamine neurons of substantia nigra. J. Neurosci. 17, 2030 (1997)
|
14 |
Simonian, N. A. and Coyle, J. T. : Oxidative stress in neurodegenerative disease. Annu. Rev. Pharmacol. Toxicol. 36, 83 (1996)
DOI
ScienceOn
|
15 |
Heikkila, R. and Cohen, G. : Futher syudies on the generation of hydrogen peroxide by 6-hydroxydopamine : Potentiation by ascorbic acid. Molecular Pharmacology 8, 241 (1972)
|
16 |
Oreland, L. : Monoamine oxidase, dopamine and Parkinson's disease. Acta. Neural. Scand. 84(Suppl 136), 60 (1991)
|
17 |
Gerlach, M., Youdim, M. B. H. and Riederer, P. : Is selegiline neuroprotective in Parkinson's disease? J. Neural Transm [suppl]. 41, 177 (1994).
|
18 |
Li, X. M., Juorio, A. V., Qi, J. and Boulton, A. A. : l-Deprenyl potentiates NGF-induced changes in superoxide dismutase mRNA in PC12 cells. J. Neurosci. Res. 53, 235 (1998)
DOI
ScienceOn
|
19 |
Olanow, C. and Arendash, G. : Metals and free radicals in neurodegeneration. Curr. Opin. Neurol. 7, 548 (1994)
DOI
ScienceOn
|
20 |
Spina, M. B., Squinto, S. P., Miller, J., Lindsay, R. M. and Hyman, C. : Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl 4-phenylpyridinium ion toxicity: Involvement of glutathione system. J. Neurochem. 59, 99 (1992)
DOI
PUBMED
|
21 |
Maruyama, W. Takahashi, T. and Naoi, M. : (-)-Deprenyl protects human doparninergic neuroblastoma SH-SY5Y cells from apoptosis induced by perowynitrite and nitric oxide. J. Neurochem. 70, 2510 (1998)
DOI
ScienceOn
|
22 |
Finberg, J. P. M., Wang, J., Goldstein, D. S., Kopin, I. J. and Bankiewics, K. S. : Influence of selective inhibition of monoamine oxidase A or B on striatal metabolism of L-DOPA in hemiparkinsonian rats. J. Neurochem. 65, 1213 (1995)
DOI
ScienceOn
|
23 |
Breese, G. and Traylor, T. D. : Effect of 6-hydroxydopamine on brain norepinephrine and dopamine: Evidence for selective degeneration of catecholamine neurons. J. Pharmcol. Exp. Ther. 174, 413 (1970)
|
24 |
Clow, A., Hussain, T., Glover, V., Sandler, M., Dexter, D. T. and Walker, M. : (-)-Deprenyl can induce soluble superoxide dismutase in rat striata. J. Neural Transm. [Gen Sect] 86, 77 (1991).
DOI
ScienceOn
|
25 |
Lowry, O. H., Rosebrough, N. J., Farr, A. L. and Randall, R. J. : Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265 (1951)
|
26 |
Wu, R. M., Chiueh, C. C., Pert, A. and Murphy, D. L. : Apperent antioxidant effect of l-deprenyl on hydroxyl adical formation and nigral injury elicited by in vivo. European Journal of Pharmacology 243, 241 (1993)
DOI
ScienceOn
|
27 |
Shimizu, S., Eguchi, Y., Kamiikie, W., Waguri, S., Uchiyama, Y., Matsuda, H. and Tsujimoto, Y. : Retardation of chemical hypoxia-induced necrotic cell death by Bcl-2 and ICE inhibitors: Possible involvement of common mediators in apoptotic and necrotic signal transductions. Oncogene 12, 2045 (1996)
|
28 |
Wu, R. M., Mohanakumar, K. P., Murphy, D. L. and Chiueh, C. C. : Antioxidant mechanism and protection of nigral neurons against toxicity by deprenyl (Selegiline). Annals New York Academy of Science. 738, 214 (1994)
DOI
|
29 |
Zuo, D. and Yu, P. H. : Increase of survival of dopaminergic neuroblastoma in co-cultures with C-6 glioma by R-(-)depreny1. Progress in Brain Research 106, 199 (1995)
|
30 |
Cohen, G. : Oxidative Stress in Nervous System, In Sies, H.(ed.) : Oxidative stress. Academic Press, London 383 (1985)
|
31 |
Grimsby, J.. Toth, M., Chen, K., Kumazawa, T., Klaidman, L., Adams, J. D., Karoum, F., Gal, J. and Shih, J. C. : Increased stress response and -phenylethylamine in MAO-B deficient mice. Nat. Genet. 17, 206 (1997)
DOI
ScienceOn
|
32 |
Portera-Cailliau, C. and Hedreen, J. C., Price, D. L. and Koliatos, V. E. : Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J. Neurosci. 15, 3775 (1995)
|
33 |
Lazebnik, Y. A., Kaufman, S. H., Desnoyers, S. Poirier, G. G. and Earnshaw, W. C. : Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371, 346 (1994)
DOI
ScienceOn
|
34 |
Blum, D., Wu, Y., Nissou, M. E, Benabid, A. L. and Verna, J. M. : p53 and Bax activation in 6-hydroxydopamine-induced apoptosis in PC12 cells. Brain Research 751, 139 (1997)
DOI
ScienceOn
|
35 |
Le, W., Jankovic, J., Xie, W., Kong, R. and Appel, S. H. : (-)-Deprenyl protection of l-methyl-4-phenylpyridium ion ( )-induced apoptosis independent of MAO-B inhibition. Neurosci. Let. 224, 197 (1997)
DOI
ScienceOn
|
36 |
Rodriguez-Gomez, J. A., Venero, J. L., Vizuete, M. L., Cano, J. and Machado, A. : Deprenyl induces the tyrosine hydroxylase enzyme in rat dopaminergic nigrostriatal system. Molecular Brain Research 46, 31 (1997)
DOI
ScienceOn
|
37 |
Maruyama, W, Naoi, M., Kasamatsu, T., Hashizume, Y., Takahashi, T., Kohda, K. and Dostert, P. An : Endogeneous dopaminergic neurotoxin, Nrnethyl-(R)-salsolinol, induces DNA damage in human dopaminergic neuroblastoma SH-SY5Y cells. J. Neurochem. 69, 322 (1997)
DOI
ScienceOn
|